Therapeutic plasma exchange improves short-term survival in patients with acute-on-chronic liver failure: A randomized controlled trial

医学 中止 随机对照试验 内科学 不利影响 临床试验 心力衰竭 子群分析 危险系数 胃肠病学 相对风险 生存分析 随机化 肝衰竭 意向治疗分析 外科 血流动力学 治疗性血浆置换 荟萃分析 存活率 肝病学 比例危险模型 血液学
作者
Shekhar Swaroop,Sagnik Biswas,Arnav Aggarwal,Poonam Coshic,Sonu Kumar,Samagra Agarwal,Hem Chandra Pandey,Gopal Kumar Patidar,Rahul Chaurasia,Umang Arora,Ayush Agarwal,Pragyan Acharya,Baibaswata Nayak,Deepak Gunjan,Viren Sardana,Ashwani Kumar Mishra,Shivanand Ramachandra Gamanagatti,S. Shalimar
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:84 (6): 1782-1794 被引量:9
标识
DOI:10.1097/hep.0000000000001755
摘要

BACKGROUND AND AIMS: This randomized controlled trial (RCT) evaluated the efficacy and safety of therapeutic plasma exchange (TPE) versus standard medical therapy (SMT) in acute-on-chronic liver failure (ACLF). APPROACH AND RESULTS: In this single-center, open-label RCT (February 2022-March 2025), we randomly (1:1) assigned 194 adult patients (aged 18-60 y) with ACLF [European Association for the Study of the Liver-Chronic Liver Failure Consortium (EASL CLIF-C) grades 1-3b] to receive SMT plus 5 sessions of TPE (n=97) or SMT alone (n=97). The primary outcome was all-cause mortality at 28 days. Secondary outcomes included 90-day mortality, changes in prognostic scores, resolution of organ failures, infections, and adverse events. Baseline characteristics were comparable between groups. Seventy-two (74.2%) patients completed 3 sessions of TPE, while 56 (57.7%) received all 5 sessions. Hemodynamic instability was the leading cause for discontinuation of TPE (18/41 patients, 43.9%). The 28-day mortality was significantly lower with TPE (43 patients, 44.3%; 95% CI: 34.2%-54.8%) than SMT (62 patients, 63.9%; 95% CI: 53.5%-73.4%), p =0.006; absolute risk reduction: 19.6% (95% CI: 5.8%-33.3%). Ninety-day mortality was similar between groups. TPE resulted in greater reductions in ammonia and higher rates of resolution of hepatic and coagulation failure by day 7 as compared with SMT. Subgroup analysis did not reveal significant heterogeneity across ACLF grade or etiology. Dyselectrolytemia and shivering were the most common complications after TPE. CONCLUSION: TPE significantly improves 28-day survival and organ failure resolution in patients with ACLF, but does not reduce 90-day mortality [CTRI/2022/01/039094].
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
nepdiana的应助被赤壁采纳,获得100
刚刚
李健的小迷弟的应助被万万采纳,获得10
刚刚
kcaj完成签到,获得积分0
1秒前
1秒前
zhuan发布了新的文献求助10
1秒前
2秒前
3秒前
miang发布了新的文献求助10
3秒前
xiao发布了新的文献求助10
3秒前
乐乐的应助被心晴采纳,获得10
3秒前
ljxx发布了新的文献求助10
3秒前
3秒前
4秒前
星辰大海的应助被夏尔酱采纳,获得10
5秒前
传奇3的应助被不喝汽水采纳,获得10
5秒前
tt完成签到,获得积分10
6秒前
111发布了新的文献求助10
6秒前
6秒前
7秒前
MARS发布了新的文献求助10
8秒前
sjy发布了新的文献求助10
8秒前
8秒前
123131发布了新的文献求助10
8秒前
Bubble完成签到,获得积分10
8秒前
灵巧一手完成签到,获得积分10
9秒前
lzx发布了新的文献求助10
9秒前
9秒前
与月舒完成签到,获得积分10
9秒前
酷波er的应助被小嫣采纳,获得10
10秒前
小巧问芙完成签到 ,获得积分10
11秒前
Hello的应助被意_采纳,获得10
11秒前
星辰大海的应助被123131采纳,获得10
12秒前
善良的采蓝完成签到,获得积分10
12秒前
彩色口红关注了科研通微信公众号
13秒前
13秒前
Owen的应助被优美的冷雪采纳,获得10
13秒前
13秒前
zar完成签到,获得积分10
14秒前
111完成签到,获得积分10
14秒前
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178375
求助须知:如何正确求助?哪些是违规求助? 9569182
关于积分的说明 21802781
捐赠科研通 7773247
什么是DOI,文献DOI怎么找? 3432799
关于科研通互助平台的介绍 2556793
邀请新用户注册赠送积分活动 2478346